G
Gisela H. Degen
Researcher at Technical University of Dortmund
Publications - 196
Citations - 5559
Gisela H. Degen is an academic researcher from Technical University of Dortmund. The author has contributed to research in topics: Genotoxicity & Chemistry. The author has an hindex of 41, co-authored 176 publications receiving 4952 citations. Previous affiliations of Gisela H. Degen include Leibniz Institute for Neurobiology & University of Karachi.
Papers
More filters
Journal ArticleDOI
Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
TL;DR: Taking existing concepts together, it is proposed to basically distinguish between "perfect" and "practical" thresholds, as well as whether the identification of possible threshold effects should also include other mechanisms of genotoxicity, in addition to aneugenic effects.
SCCP (Scientific Committee on Consumer Products) / SCHER (Scientific Committee on Health& Environment Risks) / SCENIHR (Scientific Committee on Emerging and Newly- Identified Health Risks) opinion on: Risk assessment methodologies and approaches for genotoxic and carcinogenic substances
Herman Autrup,James W. Bridges,Gisela H. Degen,Wolfgang Dekant,Helmut Greim,Hanke Wojciech,Inge Mangelsdorf,Thomas Platzek,Konrad Rydzyński,Tore Sanner,Anne Steenhout,Matti Viluksela,I. Anundi,A. Knaap,Ulrich Andrae,Peter Calow,Colin Janssen,Bo Jansson,Hannu Komulainen,Ole Ladefoged,Jan Linders,Marco Nuti,Jose Tarazona,Emanuela Testai,Marco Vighi +24 more
Journal ArticleDOI
Antioxidant activities of major thyme ingredients and lack of (oxidative) DNA damage in V79 Chinese hamster lung fibroblast cells at low levels of carvacrol and thymol.
TL;DR: Thymol and carvacrol displayed a concentration dependent antioxidant capacity, whilst gamma-terpinene which lacks a phenolic group did not show any antioxidant capacity in the trolox equivalent antioxidant capacity (TEAC) assay.
Journal ArticleDOI
Differences in aflatoxin B1-susceptibility of rat and mouse are correlated with the capability in vitro to inactivate aflatoxin B1- epoxide
Journal ArticleDOI
Endocrine Disruptors : Update on Xenoestrogens
Gisela H. Degen,H. M. Bolt +1 more
TL;DR: Consequences from previous clinical use of the potent estrogen diethyl- stilbestrol with particular emphasis on dose-response relationships, other observations in humans exposed to estrogenic chemicals in an occupational context, and available information on exposure levels of synthetic and naturally occurring estrogens in the diet are addressed.